Holen Sie sich die Stockscreener-App
77.79
0.99%
-0.8053
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$78.60
Offen:
$78.55
24-Stunden-Volumen:
4.65M
Relative Volume:
0.54
Marktkapitalisierung:
$99.91B
Einnahmen:
$35.48B
Nettoeinkommen (Verlust:
$4.64B
KGV:
21.72
EPS:
3.582
Netto-Cashflow:
$5.41B
1W Leistung:
-0.97%
1M Leistung:
-6.60%
6M Leistung:
-25.90%
1J Leistung:
-3.54%
1-Tages-Spanne:
$77.55
$78.55
1-Wochen-Bereich:
$76.98
$79.25
52-Wochen-Spanne:
$74.40
$106.33
Medtronic Plc Stock (MDT) Company Profile
Firmenname
Medtronic Plc
Sektor
Branche
Telefon
01135314381700
Adresse
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Compare MDT vs ABT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MDT
Medtronic Plc
|
77.82 | 100.91B | 35.48B | 4.64B | 5.41B | 3.582 |
ABT
Abbott Laboratories
|
86.64 | 152.25B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
312.20 | 121.33B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
57.78 | 85.88B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.72 | 49.39B | 6.30B | 1.07B | 1.09B | 1.8406 |
Medtronic Plc Stock (MDT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-13 | Fortgesetzt | Barclays | Overweight |
| 2026-02-09 | Hochstufung | Needham | Hold → Buy |
| 2026-02-03 | Fortgesetzt | Citigroup | Buy |
| 2026-01-30 | Fortgesetzt | Wells Fargo | Overweight |
| 2026-01-06 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2025-11-19 | Hochstufung | Goldman | Sell → Neutral |
| 2025-06-30 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2025-06-16 | Eingeleitet | Leerink Partners | Outperform |
| 2025-03-04 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-10-10 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-08-21 | Bestätigt | Oppenheimer | Perform |
| 2024-08-15 | Hochstufung | UBS | Sell → Neutral |
| 2024-08-14 | Herabstufung | Stifel | Buy → Hold |
| 2024-05-30 | Eingeleitet | Goldman | Sell |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Neutral |
| 2023-06-30 | Eingeleitet | CL King | Buy |
| 2023-05-30 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-24 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-03-29 | Herabstufung | UBS | Buy → Sell |
| 2023-01-09 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-11-23 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-11-23 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-11-16 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-10-18 | Eingeleitet | Barclays | Equal Weight |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-08-24 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2022-07-06 | Eingeleitet | Wolfe Research | Underperform |
| 2022-06-01 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-05-27 | Herabstufung | Needham | Buy → Hold |
| 2022-04-13 | Herabstufung | Truist | Buy → Hold |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-01-10 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-12-17 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-12-16 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-06-10 | Fortgesetzt | Cowen | Outperform |
| 2021-05-25 | Eingeleitet | Barclays | Equal Weight |
| 2021-04-15 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-12-15 | Hochstufung | Goldman | Sell → Neutral |
| 2020-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-10-08 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2020-10-08 | Hochstufung | Stifel | Hold → Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-05-14 | Herabstufung | DZ Bank | Buy → Hold |
| 2020-03-30 | Herabstufung | Needham | Strong Buy → Buy |
| 2020-03-25 | Hochstufung | DZ Bank | Hold → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Sell |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2020-01-02 | Hochstufung | Guggenheim | Neutral → Buy |
| 2019-06-05 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2019-02-04 | Bestätigt | Needham | Strong Buy |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2019-01-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2018-12-19 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-11-28 | Eingeleitet | UBS | Buy |
| 2018-10-16 | Eingeleitet | Barclays | Overweight |
| 2018-08-27 | Bestätigt | Argus | Buy |
Alle ansehen
Medtronic Plc Aktie (MDT) Neueste Nachrichten
Broad-Based MedSurg Growth Likely to Aid MDT's Q4 Performance - TradingView
Medtronic plc (MDT) Announces Intention to Acquire SPR Therapeutics (SPR) - Yahoo Finance
Medtronic makes third acquisition of 2026 with $650m SPR Therapeutics buy - BioXconomy
Medtronic Singapore partners with Society of Colorectal Surgeons to strengthen surgical training - BioSpectrum Asia
Medtronic Plc (MDT) Stock Analysis: Exploring A 36% Potential Upside For Investors - DirectorsTalk Interviews
Medtronic stock (IE00BTN1Y115): earnings momentum, portfolio moves and what’s next for diabetes an - AD HOC NEWS
/C O R R E C T I O N — Medtronic plc/ - The Malaysian Reserve
/C O R R E C T I O N -- Medtronic plc/ - Yahoo Finance
SCRS and Medtronic Singapore sign MoU to boost colorectal surgery training - Healthcare Asia Magazine
Medtronic stock (IE00BTN1Y115): earnings, diabetes pivot and what’s next for the medtech giant - AD HOC NEWS
Medtronic PLC $MDT Position Decreased by Guinness Asset Management LTD - MarketBeat
Medtronic SPR Therapeutics Deal Expands Pain Portfolio As Shares Screen Undervalued - Yahoo Finance
Is It Time To Reconsider Medtronic (MDT) After Recent Share Price Weakness? - Yahoo Finance
List of 71 Acquisitions by Medtronic (May 2026) - Tracxn
Deal Dispatch: IMAX Mulls Potential Sale, Shein Buys Everlane, West Marine Bankruptcy - Benzinga
Can MDT Stock Gain From Its Planned Acquisition of SPR Therapeutics? - TradingView
Medtronic to create European software hub in Ireland - MedTech Dive
Pzena Investment Management LLC Reduces Stock Holdings in Medtronic PLC $MDT - MarketBeat
Diamond Hill Capital Management Inc. Lowers Stake in Medtronic PLC $MDT - MarketBeat
Global Retirement Partners LLC Increases Stake in Medtronic PLC $MDT - MarketBeat
Medtronic stock (IE00BTN1Y115): earnings beat and robotic surgery partnership in focus - AD HOC NEWS
MDT Stock Price, Quote & Chart | MEDTRONIC PLC (NYSE:MDT) - ChartMill
Medtronic to acquire SPR Therapeutics for $650m - Medical Device Network
BNY Mellon Dynamic Value Fund's Medtronic PLC(MDT) Holding History - GuruFocus
Latham Advises SPR Therapeutics in Acquisition by Medtronic - Latham & Watkins LLP
Medtronic to acquire Cleveland medical tech leader SPR Therapeutics for $650 Million - Ohio Tech News
Medtronic plans to acquire SPR Therapeutics - Medical Buyer
Precision Trading with Medtronic Plc. (MDT) Risk Zones - Stock Traders Daily
IFP Advisors Inc Boosts Stake in Medtronic PLC $MDT - MarketBeat
Gabelli Funds LLC Reduces Stock Position in Medtronic PLC $MDT - MarketBeat
Guinness Atkinson Asset Management Inc's Medtronic PLC(MDT) Holding History - GuruFocus
Medtronic stock (IE00BTN1Y115): $650 million SPR Therapeutics deal puts chronic pain portfolio in fo - AD HOC NEWS
85 jobs boost as Medtronic announces European Software Development Hub in Galway - Galway Advertiser
Fast-growing Cleveland biotech firm SPR Therapeutics sold for $650M to Irish company - Crain's Cleveland Business
Medtronic’s SWOT analysis: stock navigates spin-off impact - Investing.com
Medtronic to buy SPR Therapeutics for about $650M - MedTech Dive
Medtronic plc stock (IE00BTN1Y115): SPR deal adds growth angle - AD HOC NEWS
Medtronic (MDT) Stock Slides as Company Announces $650M SPR Therapeutics Deal - Blockonomi
Medtronic (MDT) Stock: Shares Dip Amid $650M SPR Therapeutics Acquisition - CoinCentral
Medtronic data back renal denervation in the long term - MedTech Dive
Medtronic plans to buy SPR Therapeutics for $650 million to expand pain treatment options - Reuters
Medtronic stock rises as company acquires SPR Therapeutics for $650M - Investing.com Nigeria
Medtronic to acquire SPR Therapeutics for $650 million By Investing.com - Investing.com Australia
Medtronic announces intent to acquire SPR Therapeutics - marketscreener.com
Medtronic to Acquire SPR Therapeutics for $650 Million - marketscreener.com
Medtronic Plans to Acquire SPR Therapeutics for $650 Million - marketscreener.com
Medtronic to spend $650M on 60-day nerve therapy for chronic pain - Stock Titan
Medtronic PLC $MDT is Lazard Freres Gestion S.A.S.'s 10th Largest Position - MarketBeat
Suture Sleeve Kit Market Analysis 2036: Global North America Leads as Medtronic plc and Abbott Laboratories Expand - openPR.com
Resona Asset Management Co. Ltd. Cuts Stake in Medtronic PLC $MDT - MarketBeat
HighTower Advisors LLC Has $138.80 Million Stock Holdings in Medtronic PLC $MDT - MarketBeat
Finanzdaten der Medtronic Plc-Aktie (MDT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.26%
1.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):